Clinical Trial Update: A Study of Efficacy and Safety of Eltoprazine HCl for Treating Levodopa-induced Dyskinesia in Parkinson's Disease Patients [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating the efficacy and safety of eltoprazine HCl for levodopa-induced dyskinesia in Parkinson's disease; the update indicates the trial sta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyskinesia
• Parkinson Disease

Drugs mentioned

• Eltoprazine HCl (eltoprazine)

Snippet

Sponsor: Amarantus BioScience Holdings, Inc. | Conditions: Parkinson's Disease, Dyskinesia | Phase 2 | Status: UNKNOWN